| Pathway | Selection counts | | False discovery rate | Differentially expressed genes |
| Fc gamma R-mediated phagocytosis | 5 | <0.05 | <0.05 | PIP5K1B, PLCG2, PRKCA, RPS6KB1, CIN | HIF-1 signaling pathway | 5 | <0.05 | <0.05 | NFKB1, PDK1, PLCG2, PRKCA, RPS6KB1 | Phosphatidylinositol signaling system | 4 | <0.05 | <0.05 | INPP4B, PIP5K1B, PLCG2, PRKCA | Choline metabolism in cancer | 4 | <0.05 | <0.05 | PIP5K1B, PRKCA, RPS6KB1, TSC2 | Lysine degradation | 3 | <0.05 | <0.05 | EHMT1, NSD1, WHSC1 | NOD-like receptor signaling pathway | 3 | <0.05 | <0.05 | ERBB2IP, MAP3K7, NFKB1 | Thyroid hormone signaling pathway | 4 | <0.05 | <0.05 | MED12L, PLCG2, PRKCA, TSC2 | mTOR signaling pathway | 3 | <0.05 | <0.05 | PRKCA, RPS6KB1, TSC2 | Inositol phosphate metabolism | 3 | <0.05 | <0.05 | INPP4B, PIP5K1B, PLCG2 | Proteoglycans in cancer | 5 | <0.05 | <0.05 | CTTN, KB1 |
|
|